IMNM Return on Tangible Equity | Immunome, Inc.

Immunome, Inc. (IMNM) Return on Tangible Equity

2026-06-30: Return Tang Equity -48.43%.
2026-03-31: Return Tang Equity -38.15%.
2025-12-31: Return Tang Equity -33.48%.
2025-09-30: Return Tang Equity -84.40%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-48.43%
2026-03-31	-38.15%
2025-12-31	-33.48%
2025-09-30	-84.40%
2025-06-30	-78.87%
2025-03-31	-66.78%
2024-12-31	-161.71%
2024-09-30	-142.08%
2024-06-30	-103.45%
2024-03-31	-81.25%
2023-12-31	-89.09%
2023-09-30	-361.39%
2023-06-30	-280.00%
2023-03-31	-212.91%
2022-12-31	-221.56%
2022-09-30	-160.12%
2022-06-30	-119.39%
2022-03-31	-85.72%
2021-12-31	-51.28%
2021-09-30	-38.20%
2021-06-30	-35.62%
2021-03-31	-50.31%
2020-12-31	-43.14%
2020-09-30	33.99%
2020-06-30	27.05%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-33.48%
2024-12-31	-161.71%
2023-12-31	-89.09%
2022-12-31	-221.56%
2021-12-31	-51.28%
2020-12-31	-43.14%
2019-12-31	29.31%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40
SUPERNUS PHARMACEUTICALS, INC. (SUPN)	United States	$2.517B	-24.63
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
SELLAS Life Sciences Group, Inc. (SLS)	United States	$2.420B	-91.87
uniQure N.V. (QURE)		$2.416B	-4.93
MBX Biosciences, Inc. (MBX)	United States	$2.664B	-25.36
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67
NewAmsterdam Pharma Co N.V. (NAMS)		$2.719B	-15.37
Mineralys Therapeutics, Inc. (MLYS)	United States	$2.353B	-6.82